Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs
作者： K. KÜNG , J.-L. RIOND , M. WANNER
DOI: 10.1111/J.1365-2885.1993.TB00212.X
关键词: Antimicrobial 、 Cmax 、 Active ingredient 、 Ciprofloxacin 、 Oral administration 、 Pharmacology 、 Chemistry 、 Pharmacokinetics 、 Metabolite 、 Enrofloxacin
摘要: … Plasma concentrations of the active ingredient enrofloxacin and its main metabolite … to those of enrofloxacin described in the veterinary literature. Mean enrofloxacin t ½λZ was 2.4 h, …
sci-hub.se 参考文章(17)
T. Bergan, A. Dalhoff, R. Rohwedder, Pharmacokinetics of ciprofloxacin. Infection. ,vol. 16, ,(1988) , 10.1007/BF01650500
Gouyette A, Pharmacokinetics: statistical moment calculations. Drug Research. ,vol. 33, pp. 173- ,(1983)
K M Yielding, J F Prescott, In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin. Canadian Journal of Veterinary Research-revue Canadienne De Recherche Veterinaire. ,vol. 54, pp. 195- 197 ,(1990)
D.J. Mevius, H.J. Breukink, A. S. J. P. A. M. van Miert, In vitro activity of flumequine in comparison with several other antimicrobial agents against five pathogens isolated in calves in the Netherlands. Veterinary Quarterly. ,vol. 12, pp. 212- 220 ,(1990) , 10.1080/01652176.1990.9694268
Krystyna Tyczkowska, Kevin M. Hedeen, David P. Aucoin, Arthur L. Aronson, High-performance liquid chromatographic method for the simultaneous determination of enrofloxacin and its primary metabolite ciprofloxacin in canine serum and prostatic tissue Journal of Chromatography B: Biomedical Sciences and Applications. ,vol. 493, pp. 337- 346 ,(1989) , 10.1016/S0378-4347(00)82739-5
J. F. M. Nouws, J. L. Grondel, A. R. Schutte, J. Laurensen, Pharmacokinetics of ciprofloxacin in carp, African catfish and rainbow trout Veterinary Quarterly. ,vol. 10, pp. 211- 216 ,(1988) , 10.1080/01652176.1988.9694173
Peter Veng-Pedersen, Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II). Clinical Pharmacokinectics. ,vol. 17, pp. 345- 366 ,(1989) , 10.2165/00003088-198917050-00004
J. F. M. Nouws, D. J. Mevius, T. B. Vree, A. M. Baars, J. Laurensen, Pharmacokinetics, renal clearance and metabolism of ciprofloxacin following intravenous and oral administration to calves and pigs. Veterinary Quarterly. ,vol. 10, pp. 156- 163 ,(1988) , 10.1080/01652176.1988.9694165
G Hoffken, H Lode, C Prinzing, K Borner, P Koeppe, Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Antimicrobial Agents and Chemotherapy. ,vol. 27, pp. 375- 379 ,(1985) , 10.1128/AAC.27.3.375
K. FLAMMER, D. P. AUCOIN, D. A. WHITT, Intramuscular and oral disposition of enrofloxacin in African grey parrots following single and multiple doses Journal of Veterinary Pharmacology and Therapeutics. ,vol. 14, pp. 359- 366 ,(1991) , 10.1111/J.1365-2885.1991.TB00849.X